Year 2020 Vol. 28 No 3

REVIEWS

T.A. JARKENOV 1, O.G. SKIPENKO 2, M.N. ZHUMABAEV 1, S.T. ZAIROVA 3, N.A. AKATAEV 1, D.B. YESSENBAEV 1, M.M. MUKUSHEV 1, K.ZH. NURMANOV 1, M.E. BALSHAMBAEV 1

THE ASSOCIATION OF TUMOR NECROSIS FACTOR-α GENE POLYMORPHISM WITH THE SEVERITY OF ACUTE PANCREATITIS: A SYSTEMATIC REVIEW

West Kazakhstan Marat Ospanov State Medical University 1, Aktobe,
The Republic of Kazakhstan
Hepato-Pancreato-Biliary Association of Commonwealth of Independent States 2, Moscow,
The Russian Federation,
Military Institute of Air Defense Named after T.J. Begeldinov 3, Aktobe,
The Republic of Kazakhstan

Objective. The performance of a systematic review of the current literature and meta-analysis to provide the more precise estimations of the association between TNF-α gene polymorphism with the development and severity of acute pancreatitis (AP).
Methods. A systematic review, searching the Medline and Web of Science databases revealed the relevant researches. The analysis based on ten molecular genetic case-control studies of the TNF-α promoter in patients with acute pancreatitis (n=1660) and healthy volunteers (n=1618).
Results. A systematic review showed discrepant results. In three studies the association of functionally significant polymorphism -308G> A in the TNF gene promoter with a severe form of AP, development SIRS and MODS have been established. The association of -308 G / A polymorphism of the TNF gene with the risk of a developing of moderate form of acute non-biliary pancreatitis was identified in one study. In other studies the association of TNF gene polymorphism with the severity of AP was not confirmed.
Conclusions. The presented genetic studies of the TNF-α promoter at acute pancreatitis manifested the controversal results.

Keywords: acute pancreatitis, clinical course, molecular genetic studies, tumor necrosis factorα, genetic polymorphism
p. 309-317 of the original issue
References
  1. Shen HN, Lu CL, Li CY. Epidemiology of first-attack acute pancreatitis in Taiwan from 2000 through 2009: a nationwide population-based study. Pancreas. 2012 Jul;41(5):696-702. doi: 10.1097/MPA.0b013e31823db941
  2. Karakayali FY. Surgical and interventional management of complications caused by acute pancreatitis. World J Gastroenterol. 2014 Oct 7;20(37):13412-23. Published online 2014 Oct 7. doi: 10.3748/wjg.v20.i37.13412
  3. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2002;9(4):401-10. doi: 10.1007/s005340200049
  4. Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 2007 Aug;28(2):130-40. doi: 10.1097/shk.0b013e3180487ba1
  5. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007 Spring;45(2):27-37. doi: 10.1097/AIA.0b013e318034194e
  6. Chen Y, Xie CL, Hu R, Shen CY, Zeng M, Wu CQ, Chen TW, Chen C, Tang MY., Xue HD, Jin ZY, Zhang XM. Genetic Polymorphisms: A Novel Perspective on Acute Pancreatitis. Gastroenterol Res Pract. 2017;2017:5135172. doi: 10.1155/2017/5135172
  7. Whitcomb DC. Value of genetic testing in the management of pancreatitis. Gut. 2004 Nov;53(11):1710-7. doi: 10.1136/gut.2003.015511
  8. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2008 Feb;22(2):338-42. doi: 10.1096/fj.07-9492LSF
  9. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009 Jul 21;339:b2535. doi: 10.1136/bmj.b2535
  10. Balog A, Gyulai Z, Boros LG, Farkas G, Takács T, Lonovics J, Mándi Y. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas. 2005 Mar;30(2):e46-50. doi: 10.1097/01.mpa.0000153329.92686.ac
  11. Bishehsari F, Sharma A, Stello K, Toth C, O’Connell MR, Evans AC, LaRusch J, Muddana V, Papachristou GI, Whitcomb DC. TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis. Pancreatology. 2012 Mar-Apr;12(2):113-18. doi: 10.1016/j.pan.2012.02.014
  12. Liu Y, Dan G, Wu L, Chen G, Wu A, Zeng P, Xu W. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population. PLoS One. 2014 Jul 22;9(7):e103104. doi: 10.1371/journal.pone.0103104. eCollection 2014.
  13. Samgina TA, Bushueva OYu, Ivanov VP, Solodilova MA, Nazarenko PM, Polonikov AV. The association study of the promoter polymorphism -308g>a of tumor necrosis factor gene with the development and severity of acute pancreatitis in Russian population of Kursk region. Eksperimental’naia i Klinicheskaia Gastroenterologiia. 2014;109 (9):17-20. https://elibrary.ru/item.asp?id=22677286 (In Russ.)
  14. Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP. 2000 Jul;1(2):24-35. doi: 10.6092/1590-8577/423
  15. Powell JJ, Fearon KC, Siriwardena AK, Ross JA. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery. 2001 May;129(5):633-40. doi: 10.1067/msy.2001.113375
  16. Zhang DL, Li JS, Jiang ZW, Yu BJ, Tang XM, Zheng HM. Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis. World J Gastroenterol. 2003 Apr;9(4):824-28. doi: 10.3748/wjg.v9.i4.824
  17. Tukiainen E, Kylänpää ML, Puolakkainen P, Kemppainen E, Halonen K, Orpana A, Methuen T, Salaspuro M, Haapiainen R, Repo H. Polymorphisms of the TNF, CD14, and HSPA1B genes in patients with acute alcohol-induced pancreatitis. Pancreas. 2008 Jul;37(1):56-61. doi: 10.1097/MPA.0b013e31815d9bad
  18. Özhan G, Yanar HT, Ertekin C, Alpertunga B. Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis. Mediators Inflamm. 2010;2010:482950. doi: 10.1155/2010/482950
  19. Park JW, Choi JS, Han KJ, Lee SH, Kim EJ, Cho JH. Association of a genetic polymorphism of IL1RN with risk of acute pancreatitis in a Korean ethnic group. Korean J Intern Med. 2018 Nov;33(6):1103-10. doi: 10.3904/kjim.2017.133
  20. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996 Mar;83(3):349-53. doi: 10.1002/bjs.1800830317
  21. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol. 1999 Jan;94(1):213-18. doi: 10.1111/j.1572-0241.1999.00709.x
  22. Sun Y, Qi H. Relationship between the 308GA polymorphism of the tumor necrosis factor alpha gene and acute or chronic pancreatitis: a meta-analysis. Asian Biomed. 2012 Feb;6(1):1-7. doi: 10.5372/1905-7415.0601.120
  23. Yin YW, Hu AM, Sun QQ, Liu HG, Wang Q, Zeng YH, Xu RJ, Hou ZZ, Zhang SJ. Association between tumor necrosis factor-alpha gene -308A/G polymorphism and the risk of acute pancreatitis: a meta-analysis. J Surg Res. 2012 Nov;178(1):409-14. doi: 10.1016/j.jss.2012.02.001
  24. Yang Z, Qi X, Wu Q, Li A, Xu P, Fan D. Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: a meta-analysis. Gene. 2012 Jul 25;503(2):229-34. doi: 10.1016/j.gene.2012.04.057
  25. Farkas G Jr, Hofner P, Balog A, Takács T, Szabolcs A, Farkas G, Mándi Y. Relevance of transforming growth factor-beta1, interleukin-8, and tumor necrosis factor-alpha polymorphisms in patients with chronic pancreatitis. Eur Cytokine Netw. 2007 Mar;18(1):31-37. doi: 10.1684/ecn.2007.0084
  26. Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 2007 Aug;28(2):130-40. doi: 10.1097/shk.0b013e3180487ba1
Address for correspondence:
030019, Republic of Kazakhstan,
Aktobe, Maresyev str., 68,
West Kazakhstan Marat Ospanov Medical University, Surgical Diseases In the absenc No 1,
tel. +7 7132 544297,
e-mail: timurjarkenov@gmail.com,
Timur A. Jarkenov
Information about the authors:
Jarkenov Timur A.,MD, Professor of the Surgical Diseases Department No 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0003-4579-6412
Skipenko Oleg G., MD, Professor, Member of Board of Hepato-Pancreato-Biliary Association of Commonwealth of Independent States, Moscow, Russian Federation.
https://orcid.org/0000-0002-4192-9620
Zhumabaev Marat N., PhD, Associate Professor, Head of the Surgical Diseases Department No1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0002-5092-6034
Zairova SauleT., PhD, Military Institute of Air Defense Named after T.J. Begeldinov, Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0003-3734-6884
Akataev Nagashybai A., PhD, Professor of the Surgical Diseases Department No1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0001-8964-5152
Yessenbaev Daulet B., Assistant of the Surgical Diseases Department No1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0001-9777-0594
Mukushev Manas M., PhD, Associate Professor of the Surgical Diseases Department No1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan
https://orcid.org/0000-0003-1811-3276
Nurmanov Kairat Zh., Assistant of the Surgical Diseases Department No1, West Kazakhstan Marat Ospanov Medical University), Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0003-1422-7524
Balshambayev Madi E., Assistant of the Surgical Diseases Department No1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan.
https://orcid.org/0000-0002-0206-1769
Contacts | ©Vitebsk State Medical University, 2007-2023